Jennifer Wu

1.2k total citations · 1 hit paper
17 papers, 639 citations indexed

About

Jennifer Wu is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Jennifer Wu has authored 17 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Dermatology, 6 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Jennifer Wu's work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Chemotherapy-related skin toxicity (4 papers). Jennifer Wu is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Chemotherapy-related skin toxicity (4 papers). Jennifer Wu collaborates with scholars based in Taiwan, United States and Italy. Jennifer Wu's co-authors include Mario E. Lacouture, Gregory S. Phillips, Amaris Geisler, Dulce M. Barrios, Donald Y.M. Leung, Jeffrey A. Kern, Andrea P. Moy, Chau Yee Ng, Rosaline Chung‐Yee Hui and Chun‐Wei Lu and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Journal of the American Academy of Dermatology.

In The Last Decade

Jennifer Wu

17 papers receiving 633 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune checkpoint inhibitor–related dermatologic adverse events

2020 298 citations Amaris Geisler, Gregory S. Phillips et al. Journal of the American Academy of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer Wu Taiwan	8	338	165	154	129	104	17	639
Émmanuelle Vigarios France	12	402 1.2×	70 0.4×	193 1.3×	112 0.9×	119 1.1×	39	729
Gregory S. Phillips United States	6	325 1.0×	66 0.4×	118 0.8×	79 0.6×	81 0.8×	7	479
Alyx Rosen United States	12	274 0.8×	54 0.3×	174 1.1×	42 0.3×	130 1.3×	19	507
Eun Bong Lee South Korea	11	64 0.2×	37 0.2×	43 0.3×	76 0.6×	70 0.7×	14	509
J. Espinós Spain	12	232 0.7×	64 0.4×	26 0.2×	26 0.2×	76 0.7×	48	718
Rajni Mandal United States	14	190 0.6×	9 0.1×	73 0.5×	72 0.6×	75 0.7×	27	532
Iris Isufi United States	12	283 0.8×	8 0.0×	62 0.4×	159 1.2×	96 0.9×	61	535
Dominique Cazals France	9	247 0.7×	12 0.1×	30 0.2×	143 1.1×	138 1.3×	11	525
Amy Musiek United States	16	141 0.4×	14 0.1×	360 2.3×	179 1.4×	99 1.0×	60	569
Antonella Teramo Italy	16	144 0.4×	29 0.2×	20 0.1×	271 2.1×	99 1.0×	38	722

Countries citing papers authored by Jennifer Wu

Since Specialization

Citations

This map shows the geographic impact of Jennifer Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Wu more than expected).

Fields of papers citing papers by Jennifer Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Wu. The network helps show where Jennifer Wu may publish in the future.

Co-authorship network of co-authors of Jennifer Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Wu. A scholar is included among the top collaborators of Jennifer Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Wu. Jennifer Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Liao, Yi‐Hua, et al.. (2023). Taiwanese Dermatological Association (TDA) consensus recommendations for the definition, classification, diagnosis, and management of hidradenitis suppurativa. Journal of the Formosan Medical Association. 123(12). 1228–1238. 1 indexed citations

Wu, Jennifer, Michael Offin, Cecilia Lezcano, et al.. (2021). Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers. Investigational New Drugs. 39(3). 785–795. 21 indexed citations

Geisler, Amaris, Gregory S. Phillips, Dulce M. Barrios, et al.. (2020). Immune checkpoint inhibitor–related dermatologic adverse events. Journal of the American Academy of Dermatology. 83(5). 1255–1268. 298 indexed citations breakdown →

Wu, Jennifer, et al.. (2020). Cutaneous toxicities of targeted therapies in the treatment of hepatocellular carcinoma. Hepatoma Research. 2020. 2 indexed citations

Chen, Chun‐Bing, Chau Yee Ng, Chun‐Wei Lu, et al.. (2018). Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies. Cancer Management and Research. Volume 10. 1259–1273. 109 indexed citations

Ng, Chau Yee, Chun‐Bing Chen, Jennifer Wu, et al.. (2018). Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies. Journal of Immunology Research. 2018. 1–9. 44 indexed citations

Ng, Chau Yee, et al.. (2018). Acquired perforating calcific collagenosis in a drug addict with rhabdomyolysis and transient hypercalcemia. Journal of Cutaneous Pathology. 46(1). 84–87. 2 indexed citations

Wu, Jennifer & Mario E. Lacouture. (2018). Pruritus Associated with Targeted Anticancer Therapies and Their Management. Dermatologic Clinics. 36(3). 315–324. 29 indexed citations

Phillips, Gregory S., Azael Freites‐Martínez, Jennifer Wu, et al.. (2018). Clinical Characterization of Immunotherapy-Related Pruritus Among Patients Seen in 2 Oncodermatology Clinics. JAMA Dermatology. 155(2). 249–249. 38 indexed citations

10.

Wu, Jennifer, Azael Freites‐Martínez, Matthew D. Hellmann, et al.. (2018). Treatment outcomes of cutaneous adverse events to immune checkpoint inhibitors.. Journal of Clinical Oncology. 36(15_suppl). e22093–e22093. 1 indexed citations

11.

McKay, Tina B., Jesper Hjortdal, Henrik Sejersen, et al.. (2016). Endocrine and Metabolic Pathways Linked to Keratoconus: Implications for the Role of Hormones in the Stromal Microenvironment. Scientific Reports. 6(1). 25534–25534. 60 indexed citations

12.

Wu, Jennifer, et al.. (2015). Multiple eruptive myxoid dermatofibromas. Dermatologica Sinica. 34(1). 46–48. 2 indexed citations

13.

Wu, Jennifer, et al.. (2015). Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with malignancies. British Journal of Dermatology. 173(5). 1224–1231. 27 indexed citations

14.

Kinlaw, Alan C., Michele Jönsson Funk, Mitchell M. Conover, Elizabeth J. Geller, & Jennifer Wu. (2014). Comparative Safety of Antimuscarinics among Adults in the United States, 2000–2011. Neurourology and Urodynamics. 1 indexed citations

15.

Shah, Ami A. & Jennifer Wu. (2014). Management of incidental esophageal uptake on FDG PET/CT. BMJ Case Reports. 2014. bcr2014203845–bcr2014203845. 2 indexed citations

16.

Wu, Jennifer, et al.. (2012). Targeted Therapy: Its Status and Promise in Selected Solid Tumors Part I. 1 indexed citations

17.

Yan, Y., Jill M. Spoerke, Jennifer Wu, et al.. (2012). 495 The PI3K/mTOR Inhibitor GDC-0980 Demonstrates Target Engagement and Pathway Modulation in Tumor Tissue at Tolerated Doses. European Journal of Cancer. 48. 153–153. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact